Greenstreet Yvonne

CIK 00014461253 companiesCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001446125

Recent Transactions

50 trades

Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2026-01-12$370.87/sh−118→ 78,732 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2026-01-12$366.41/sh−316→ 79,948 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2026-01-12$353.95/sh−247→ 87,741 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2026-01-12$361.45/sh−624→ 83,683 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2026-01-12$372.46/sh−21→ 78,711 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2026-01-12$377.82/sh−94→ 78,411 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2026-01-12$369.48/sh−253→ 78,850 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2026-01-12$362.38/sh−464→ 83,219 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2026-01-12$368.62/sh−584→ 79,103 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2026-01-12$367.40/sh−261→ 79,687 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2026-01-12$357.17/sh−607→ 86,602 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2026-01-12$356.09/sh−263→ 87,209 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2026-01-12$355.16/sh−269→ 87,472 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2026-01-12$374.44/sh−88→ 78,623 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2026-01-12$365.56/sh−1,395→ 80,264 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2026-01-12$358.18/sh−778→ 85,824 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2026-01-12$375.65/sh−118→ 78,505 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2026-01-12$360.22/sh−980→ 84,307 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2026-01-12$363.55/sh−301→ 82,918 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2026-01-12$359.14/sh−537→ 85,287 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2026-01-12$364.83/sh−1,259→ 81,659 total
Award
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2026-01-11+19,003→ 87,988 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (right to buy)
2025-11-26−847→ 0 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2025-11-26$118.05/sh+847→ 69,447 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (right to buy)
2025-11-26−2,352→ 0 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2025-11-26$85.00/sh+2,352→ 68,600 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2025-11-26$119.13/sh+839→ 66,248 total
Tax Payment
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2025-11-26$445.12/sh−1,121→ 68,985 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (right to buy)
2025-11-26−659→ 28,141 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2025-11-26$151.59/sh+659→ 70,106 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (right to buy)
2025-11-26−839→ 0 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2025-11-13$454.69/sh−195→ 65,670 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2025-11-13$453.99/sh−881→ 65,865 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2025-11-13$456.03/sh−261→ 65,409 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Performance Stock Option 2017 (right to buy)
2025-11-13−10,000→ 0 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2025-11-13$119.13/sh+10,000→ 75,409 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2025-11-13$447.73/sh−654→ 74,755 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2025-11-13$451.94/sh−1,702→ 68,345 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2025-11-13$452.85/sh−1,599→ 66,746 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2025-11-13$450.02/sh−1,477→ 72,265 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2025-11-13$448.76/sh−1,013→ 73,742 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2025-11-13$450.69/sh−2,218→ 70,047 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2025-11-12$456.64/sh−2,420→ 66,443 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Performance Stock Option 2016 (right to buy)
2025-11-12−650→ 0 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2025-11-12$451.16/sh−1,255→ 76,508 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2025-11-12$119.13/sh+15,000→ 81,059 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2025-11-12$455.56/sh−3,406→ 68,863 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2025-11-12$452.43/sh−1,210→ 75,298 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2025-11-12$457.71/sh−604→ 65,839 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Performance Stock Option 2017 (right to buy)
2025-11-12−15,000→ 10,000 total

Companies

Recent Filings

4
Greenstreet Yvonne
Jan 14, 2026

Address

675 WEST KENDALL STREET HENRI A. TERMEER SQUARE

CAMBRIDGE, MA, 02142

View on SEC.gov